OPENLANE's Coleman exercises options, sells shares

The transactions paired option exercises with sales of matching share amounts across two consecutive dates.

Available on EDGAR 11/09/2026 - 11:28 AM EST Accepted by SEC EDGAR 11/09/2026 - 11:27 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

OPENLANE, Inc. EVP, CLO & Secretary Charles S. Coleman exercised employee stock options and sold matching amounts of common stock on November 6 and November 5, 2026. On November 6, he exercised options for 9,594 shares at $13.81 and 28,500 shares at $18.23, then sold matching amounts at reported weighted-average prices of $35.65 per share; the sales were in multiple transactions at $35.50 to $35.95. On November 5, he exercised options for 300 shares at $18.23 and 102 shares at $13.81, then sold those amounts at reported weighted-average prices of $36.05 and $36.08; the sales were in multiple transactions at $36.00 to $36.08. No Rule 10b5-1 plan is reported.

Insider Trade Summary

Exercise and Sale: 38,496 shares ($714K approx. pre-tax spread)

Exercise and Sale 12 txns

Insider Coleman Charles S.

Role EVP, CLO & Secretary

Sold 38,496 shs ($1.37M)

Approx. gross sale proceeds $1.37M

Approx. exercise cost $659K

Approx. pre-tax spread $714K

Type	Security	Shares	Price	Value
Exercise	Employee Stock Option (right to buy) F4	9,594	$13.81	$132K
Exercise	Employee Stock Option (right to buy) F3	28,500	$18.23	$520K
Exercise	Common Stock	9,594	$13.81	$132K
Sale	Common Stock F2	9,594	$35.65	$342K
Exercise	Common Stock	28,500	$18.23	$520K
Sale	Common Stock F2	28,500	$35.65	$1.02M
Exercise	Employee Stock Option (right to buy) F3	300	$18.23	$5K
Exercise	Employee Stock Option (right to buy) F4	102	$13.81	$1K
Exercise	Common Stock	300	$18.23	$5K
Sale	Common Stock F1	300	$36.05	$11K
Exercise	Common Stock	102	$13.81	$1K
Sale	Common Stock F1	102	$36.08	$4K

Holdings After Transaction: Employee Stock Option (right to buy) — 39,976 options (Direct); Common Stock — 74,334 shares (Direct)

Footnotes (4)

1. F1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.08 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
2. F2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.50 to $35.95 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. F3. These options were granted on June 4, 2021 and became eligible to vest and became exercisable in equal 25% increments, each upon the later of the occurrence of the first four anniversaries of the grant date, respectively, and the attainment of the closing price of the Company's common stock at or above, for each respective 25% increment, $23.23, $28.23, $33.23, and $38.23, for twenty consecutive trading days, subject to continued employment through such vesting date.
4. F4. These options were granted on March 4, 2021 and became eligible to vest and became exercisable in equal 25% increments, each upon the later of the occurrence of the first four anniversaries of the grant date, respectively, and the attainment of the closing price of the Company's common stock at or above, for each respective 25% increment, $18.81, $23.81, $28.81, and $33.81, for twenty consecutive trading days, subject to continued employment through such vesting date.

Key Figures

Option exercise: 9,594 shares at $13.81 per share Option exercise: 28,500 shares at $18.23 per share Shares sold at weighted-average price: 9,594 shares at $35.65 per share +5 more

8 metrics

Option exercise 9,594 shares at $13.81 per share November 6, 2026

Option exercise 28,500 shares at $18.23 per share November 6, 2026

Shares sold at weighted-average price 9,594 shares at $35.65 per share November 6, 2026

Shares sold at weighted-average price 28,500 shares at $35.65 per share November 6, 2026

Option exercise 300 shares at $18.23 per share November 5, 2026

Option exercise 102 shares at $13.81 per share November 5, 2026

Shares sold at weighted-average price 300 shares at $36.05 per share November 5, 2026

Shares sold at weighted-average price 102 shares at $36.08 per share November 5, 2026

Key Terms

weighted average price, equal 25% increments, twenty consecutive trading days

3 terms

weighted average price financial

"The price reported in column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

equal 25% increments financial

"became exercisable in equal 25% increments"

twenty consecutive trading days financial

"for twenty consecutive trading days"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many OPLN shares did Charles S. Coleman exercise and sell on November 6, 2026?

He exercised options for 9,594 shares at $13.81 per share and 28,500 shares at $18.23 per share, then sold matching amounts at reported weighted-average prices of $35.65 per share. The sales were in multiple transactions at $35.50 to $35.95 per share. No Rule 10b5-1 plan is reported.

What OPLN stock transactions did Charles S. Coleman report for November 5, 2026?

He exercised options for 300 shares at $18.23 per share and 102 shares at $13.81 per share, then sold matching amounts at reported weighted-average prices of $36.05 and $36.08 per share. The sales were in multiple transactions at $36.00 to $36.08 per share. No Rule 10b5-1 plan is reported.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Coleman Charles S.

(Last) (First) (Middle)

C/O: OPENLANE, INC.

11299 NORTH ILLINOIS STREET

(Street)

CARMEL INDIANA 46032

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
OPENLANE, Inc. [ OPLN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, CLO & Secretary

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/05/2026		M		300	A	$18.23	74,634	D
Common Stock	11/05/2026		S		300	D	$36.05(1)	74,334	D
Common Stock	11/05/2026		M		102	A	$13.81	74,436	D
Common Stock	11/05/2026		S		102	D	$36.08(1)	74,334	D
Common Stock	11/06/2026		M		9,594	A	$13.81	83,928	D
Common Stock	11/06/2026		S		9,594	D	$35.65(2)	74,334	D
Common Stock	11/06/2026		M		28,500	A	$18.23	102,834	D
Common Stock	11/06/2026		S		28,500	D	$35.65(2)	74,334	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$18.23	11/05/2026		M			300	(3)	06/04/2031	Common Stock	300	$18.23	58,409	D
Employee Stock Option (right to buy)	$13.81	11/05/2026		M			102	(4)	03/04/2031	Common Stock	102	$13.81	19,661	D
Employee Stock Option (right to buy)	$13.81	11/06/2026		M			9,594	(4)	03/04/2031	Common Stock	9,594	$13.81	10,067	D
Employee Stock Option (right to buy)	$18.23	11/06/2026		M			28,500	(3)	06/04/2031	Common Stock	28,500	$18.23	29,909	D

Explanation of Responses:

1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.08 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.50 to $35.95 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. These options were granted on June 4, 2021 and became eligible to vest and became exercisable in equal 25% increments, each upon the later of the occurrence of the first four anniversaries of the grant date, respectively, and the attainment of the closing price of the Company's common stock at or above, for each respective 25% increment, $23.23, $28.23, $33.23, and $38.23, for twenty consecutive trading days, subject to continued employment through such vesting date.

4. These options were granted on March 4, 2021 and became eligible to vest and became exercisable in equal 25% increments, each upon the later of the occurrence of the first four anniversaries of the grant date, respectively, and the attainment of the closing price of the Company's common stock at or above, for each respective 25% increment, $18.81, $23.81, $28.81, and $33.81, for twenty consecutive trading days, subject to continued employment through such vesting date.

Remarks:

	Charles S. Coleman	11/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)